Changing Management Guidelines in Thyrotoxic Hypokalemic Periodic Paralysis

Area of Science:

• Endocrinology
• Neurology

Background:

• Periodic paralysis is a rare complication of hyperthyroidism, predominantly affecting individuals of East Asian descent.
• It manifests as recurrent, painless episodes of abrupt-onset weakness.
• Laboratory findings typically reveal profound hypokalemia, and the underlying hyperthyroidism may be subclinical.

Observation:

• This case report details a 22-year-old male with undiagnosed hyperthyroidism experiencing recurrent, relapsing-remitting weakness.
• Obese patients are at increased risk due to insulin resistance enhancing sodium-potassium ATPase activity.
• The hypokalemia observed is functional in nature.

Findings:

• Hyperthyroidism should be suspected in patients presenting with acute-onset paralysis and significant hypokalemia or relapsing-remitting symptoms.
• Nonselective beta-blockers, like propranolol, are recommended as first-line treatment.
• These agents decrease ATPase activity, limit insulin secretion, and manage the underlying hyperthyroid disorder.

Implications:

• Emergency physicians must consider hyperthyroidism in the differential diagnosis of acute paralysis with hypokalemia.
• Differentiating this condition from familial periodic paralysis is critical due to distinct treatment strategies.
• Caution is advised when administering exogenous potassium, as excessive amounts can lead to dangerous rebound hyperkalemia.